These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 6687550)

  • 1. Pharmacokinetics of atracurium besylate in healthy patients (after a single i.v. bolus dose).
    Ward S; Neill EA; Weatherley BC; Corall IM
    Br J Anaesth; 1983 Feb; 55(2):113-8. PubMed ID: 6687550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of atracurium in acute hepatic failure (with acute renal failure).
    Ward S; Neill EA
    Br J Anaesth; 1983 Dec; 55(12):1169-72. PubMed ID: 6689126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined pharmacokinetic and pharmacodynamic study of a single bolus dose of atracurium.
    Ward S; Wright D
    Br J Anaesth; 1983; 55 Suppl 1():35S-38S. PubMed ID: 6688015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of atracurium besylate in the pig after a single i.v. injection.
    Schopfer C; Pittet JF; Morel DR; Tassonyi E; Benakis A
    Eur J Drug Metab Pharmacokinet; 1989; 14(4):299-302. PubMed ID: 2633924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics, pharmacodynamics and dose-response relationships of atracurium administered i.v.
    Weatherley BC; Williams SG; Neill EA
    Br J Anaesth; 1983; 55 Suppl 1():39S-45S. PubMed ID: 6688016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of 1R-cis 1'R-cis atracurium besylate (51W89) and plasma laudanosine concentrations in health and chronic renal failure.
    Eastwood NB; Boyd AH; Parker CJ; Hunter JM
    Br J Anaesth; 1995 Oct; 75(4):431-5. PubMed ID: 7488483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of atracurium and laudanosine in the elderly.
    Kent AP; Parker CJ; Hunter JM
    Br J Anaesth; 1989 Dec; 63(6):661-6. PubMed ID: 2611066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the pharmacodynamics and pharmacokinetics of an infusion of cis-atracurium (51W89) or atracurium in critically ill patients undergoing mechanical ventilation in an intensive therapy unit.
    Boyd AH; Eastwood NB; Parker CJ; Hunter JM
    Br J Anaesth; 1996 Mar; 76(3):382-8. PubMed ID: 8785138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of extreme obesity on the body disposition and neuromuscular blocking effect of atracurium.
    Varin F; Ducharme J; Théorêt Y; Besner JG; Bevan DR; Donati F
    Clin Pharmacol Ther; 1990 Jul; 48(1):18-25. PubMed ID: 2369806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and neuromuscular blocking effects of atracurium besylate and two of its metabolites in patients with normal and impaired renal function.
    Vandenbrom RH; Wierda JM; Agoston S
    Clin Pharmacokinet; 1990 Sep; 19(3):230-40. PubMed ID: 2394062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of age on cis-atracurium besylate pharmacokinetics following a single 1 mg kg
    Aguilar A; Andaluz A; Moll X; Cristòfol C; García F
    Vet Anaesth Analg; 2019 Sep; 46(5):643-651. PubMed ID: 31155378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of the organ-independent elimination of cisatracurium.
    Kisor DF; Schmith VD; Wargin WA; Lien CA; Ornstein E; Cook DR
    Anesth Analg; 1996 Nov; 83(5):1065-71. PubMed ID: 8895287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of atracurium and laudanosine in patients with hepatic cirrhosis.
    Parker CJ; Hunter JM
    Br J Anaesth; 1989 Feb; 62(2):177-83. PubMed ID: 2923767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of 51W89: preliminary data.
    Hunter JM; Eastwood NB; Boyd AH; Parker CJ
    Acta Anaesthesiol Scand Suppl; 1995; 106():94. PubMed ID: 8533555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacokinetics and pharmacodynamics of atracurium in patients with and without renal failure.
    Fahey MR; Rupp SM; Fisher DM; Miller RD; Sharma M; Canfell C; Castagnoli K; Hennis PJ
    Anesthesiology; 1984 Dec; 61(6):699-702. PubMed ID: 6239574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro degradation of atracurium in human plasma.
    Merrett RA; Thompson CW; Webb FW
    Br J Anaesth; 1983 Jan; 55(1):61-6. PubMed ID: 6687375
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro degradation of atracurium in human plasma.
    Stiller RL; Cook DR; Chakravorti S
    Br J Anaesth; 1985 Nov; 57(11):1085-8. PubMed ID: 3840382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model for atracurium?
    Hull CJ
    Br J Anaesth; 1983 Feb; 55(2):95-6. PubMed ID: 6687551
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetics of atracurium and its metabolites.
    Ward S; Weatherley BC
    Br J Anaesth; 1986; 58 Suppl 1():6S-10S. PubMed ID: 3754756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of atracurium and its metabolites in patients with normal renal function, and in patients in renal failure.
    Ward S; Boheimer N; Weatherley BC; Simmonds RJ; Dopson TA
    Br J Anaesth; 1987 Jun; 59(6):697-706. PubMed ID: 3606914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.